P

PureIMS

9 employees

PureIMS provides dry powder inhalation, compounding clinical trial medication, compounding pharmacy, and pulmonary administration services.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pulmonary administration
Cystic Fibrosis
Compounding clinical trial medication
Clinical trials
Parkinson disease
Development of dry powder inhalers
Clinical Trials
Compounding pharmacy
Tuberculosis
Infectious diseases
Dry powder inhalation
Life Science

Date founded

2014

Funding rounds raised

P

PureIMS raised undisclosed on April 3, 2023

Investors: Carduso Capital B.V and Balsz Elementary School

FAQ